PAOG Highlights ALKM $15 Million Production Facility In Conjunction With CBD Nutraceutical Plan Targeting $5 Billion Market
Sandusky, Ohio--(Newsfile Corp. - May 27, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today highlighted Alkame Holdings, Inc's (OTC Pink: ALKM) recent news reporting the near completion status of its new production facility:ALKM - Alkame Confirms $15 Million Annual Revenue Bottling Production PotentialPAOG recenlty released a preview of the company's plan to launch a CBD Nutraceuticals line of products. PAOG's CBD Nutraceuticals are expected to generate revenue this year, in 2021, while the...
2021-05-27 2:34 PM EDT
PAOG Targets International Segment of $5 Billion CBD Nutraceutical Market
Sandusky, Ohio--(Newsfile Corp. - May 13, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today revealed it will include foreign sales in the planned Q4 launch of its three CBD Nutraceutical Products.The 2020 CBD Nutraceuticals Market had an estimated value of $5.2 Billion and it is expected to reach $16.4 Billion by 2027.That market value represents global sales. PAOG management is targeting specific international segments to be included in its Q4 sales launch. PAOG management anticipates a...
2021-05-13 9:22 AM EDT
PAOG Confirms CBD Nutraceutical Q4 Revenue Plans
Sandusky, Ohio--(Newsfile Corp. - May 11, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed plans to introduce three CBD Nutraceutical Products beginning in the fourth quarter of this year, 2021.On Friday, PAOG released a preview of the company's plan to launch a CBD Nutraceuticals line of products. PAOG's CBD Nutraceuticals are expected to generate revenue this year, in 2021, while the company continues with its long-term CBD pharmaceutical developments.PAOG is working on the...
2021-05-11 2:58 PM EDT
PAOG Releases CBD Nutraceutical 2021 Product Launch Preview Highlighting PURA EVERx Partnership, ALKM Co-Packing and USMJ Distribution
Sandusky, Ohio--(Newsfile Corp. - May 7, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today released a preview of the company's plan to launch a CBD Nutraceuticals line of products. PAOG's CBD Nutraceuticals are expected to generate revenue this year, in 2021, while the company continues with its long-term CBD pharmaceutical developments.PAOG is working on the development of a CBD pharmaceutical product under the name RespRx, for the treatment of Chronic Obstructive Pulmonary Disorder (COPD)...
2021-05-07 8:42 AM EDT
PAOG 2021 CBD Nutraceuticals Rollout Preview This Friday
Sandusky, Ohio--(Newsfile Corp. - May 5, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed a CBD Nutraceutical Sales Rollout Presentation scheduled this Friday, May 7, 2021.Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT...
2021-05-05 12:12 PM EDT
PAOG CBD Nutraceuticals to Hit Market This Year
Sandusky, Ohio--(Newsfile Corp. - May 4, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed plans to present the Company's CBD Nutraceutical Sales Rollout Plan this Friday, May 7, 2021.Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled, "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS...
2021-05-04 8:59 AM EDT
PAOG 2021 CBD Nutraceutical Sales Rollout Plan Presentation Scheduled This Friday
Sandusky, Ohio--(Newsfile Corp. - May 3, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today announced plans to present the company's CBD Nutraceutical Sales Rollout Plan this Friday, May 7, 2021.Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS...
2021-05-03 3:22 PM EDT
PAOG Anticipates Boost to CBD Pharmaceutical Research Initiative from Improving Cannabis Legalization Outlook
Sandusky, Ohio--(Newsfile Corp. - April 28, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today highlighted recent cannabis legalization progress anticipated to enhance PAOG's ongoing CBD Pharmaceutical Development Program.PAOG has partnered with Puration, Inc. (OTC Pink: PURA) to build a pharmaceutical grade indoor hemp grow facility and CBD extraction facility in conjunction with PURA's Farmersville Hemp Brand project in Texas. PURA Farmersville Hemp Brand project partners also include Alkame...
2021-04-28 12:13 PM EDT
PAOG Announces Opportunity To Expand CBD Pharmaceutical Research
Sandusky, Ohio--(Newsfile Corp. - April 13, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today released a management update on the company's ongoing CBD Pharmaceutical Development Program. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled, "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT...
2021-04-13 10:28 AM EDT
PAOG CBD Pharmaceutical Development Update Coming Tomorrow, Tuesday April 13, 2021
Sandusky, Ohio--(Newsfile Corp. - April 12, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed a management update on the Company's ongoing CBD Pharmaceutical Development Program progress scheduled to be released next week on Tuesday, April 13, 2021.Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No....
2021-04-12 11:00 AM EDT
PAOG Advances CBD Pharmaceutical Developments Backed By US Patent
Sandusky, Ohio--(Newsfile Corp. - April 8, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today announced a management update on the company's ongoing CBD Pharmaceutical Development Program progress scheduled to be released next week on Tuesday, April 13, 2021.Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No....
2021-04-08 11:39 AM EDT
PAOG Targets September 2021 to Introduce CBD Nutraceuticals to Market Co-Packed by ALKM and Marketed Through USMJ
Sandusky, Ohio--(Newsfile Corp. - March 16, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today released details on the Company's nutraceutical developments initiative following last week's introduction of adding CBD RELAX-RX to existing CBD RespRx developments. The details today are highlighted by the Company's September 2021 go-to-market target date with nutraceutical co-packing to be conducted by Alkame Holdings, Inc. (OTC Pink: ALKM) and product marketing to be conducted by North American...
2021-03-16 9:09 AM EDT
PAOG Announces Save The Date For CBD Nutraceuticals Expansion Update
Sandusky, Ohio--(Newsfile Corp. - March 10, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today encouraged all interested to save the date, Tuesday, March 16, 2021, when PAOG will publish details on the company's CBD RELAX-RX nutraceutical development plans including intended co-packing with Alkame Holdings, Inc. (OTC Pink: ALKM) and marketing with North American Cannabis Holdings, Inc. (OTC Pink: USMJ).CBD RELAX-RX targets the anxiety and depression treatment market anticipated to reach a value...
2021-03-10 1:07 PM EST
PAOG CBD RELAX-RX Co-Packing with ALKM And Marketing with USMJ Detailed In Update Scheduled Next Week
Sandusky, Ohio--(Newsfile Corp. - March 9, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today announced an update scheduled one week from today, for Tuesday, March 16, 2021 to publish details on the company's CBD RELAX-RX nutraceutical development plans including intended co-packing with Alkame Holdings, Inc. (OTC Pink: ALKM) and marketing with North American Cannabis Holdings, Inc. (OTC Pink: USMJ).CBD RELAX-RX targets the anxiety and depression treatment market anticipated to reach a value of...
2021-03-09 12:58 PM EST
PAOG Announces RELAX-RX Nutraceutical For $18 Billion Anxiety And Depression Treatment Market
Sandusky, Ohio--(Newsfile Corp. - March 8, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today announced initiating the development of its new nutraceutical, RELAX-RX, targeting the anxiety and depression treatment market anticipated to reach a value of $18 billion by 2025.The company recently announced plans to produce a variety of nutraceuticals for additional applications beyond the current focus on care for those experiencing issues associated with Chronic Obstructive Pulmonary Disorder...
2021-03-08 11:04 AM EST
PAOG Expects To Realize Revenue This Year From New CBD Nutraceuticals
Sandusky, Ohio--(Newsfile Corp. - February 18, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today highlighted the company's anticipated revenue expected this year from its CBD nutraceutical expansion. Earlier this week, the company published an online, multimedia presentation detailing the company's CBD nutraceutical development expansion plans. The presentation includes details on PAOG's strategic engagements with Puration, Inc. (OTC Pink: PURA), North American Cannabis Holdings, Inc. (OTC Pink:...
2021-02-18 9:43 AM EST
PAOG Announces CBD Nutraceuticals Expansion Plan Multimedia Presentation
Sandusky, Ohio--(Newsfile Corp. - February 16, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today published an online, multimedia presentation detailing the Company's CBD nutraceutical development expansion plans. The CBD nutraceutical development expansion plans are anticipated to generate revenue beginning this year, in 2021 adding to the Company's previously announced anticipated revenue for 2021.PAO Group, Inc
2021-02-16 8:58 AM EST
PAOG Targets $18 Billion Anxiety And Depression Treatment Market
Sandusky, Ohio--(Newsfile Corp. - February 11, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today announced the company's recently announced CBD nutraceutical development expansion will target the anxiety and depression treatment market anticipated to reach a value of $18 billion by 2025.The company recently announced plans to produce a variety of nutraceuticals for additional applications beyond the current focus on care for those experiencing issues associated with Chronic Obstructive Pulmonary...
2021-02-11 9:07 AM EST
PAOG Plans To Add CBD Nutraceutical Revenue In 2021 To Cannabis Cultivation Revenue
Sandusky, Ohio--(Newsfile Corp. - February 10, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today announced the company plans to add revenue this year in 2021 from its developing CBD nutraceutical business to currently anticipated revenue from its cannabis cultivation business revenue.PAOG recently announced that it anticipated reporting approximately $50,000 in revenue in Q4 2020 from its cannabis cultivation business acquired last year from Puration, Inc. (OTC Pink: PURA). The Q4 2020 revenue...
2021-02-10 9:03 AM EST
PAOG Announces CBD Nutraceuticals Expansion Plan for $3.8 Billion Market Presentation Scheduled Next Week
Sandusky, Ohio--(Newsfile Corp. - February 8, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today announced plans to publish a multimedia presentation next week on the company's strategy to expand its nutraceutical product reach. The company plans to produce nutraceuticals for additional applications beyond the current focus on care for those experiencing issues associated with Chronic Obstructive Pulmonary Disorder (COPD). The presentation is scheduled to be published next week on Tuesday, Feb...
2021-02-08 9:09 AM EST